Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery

Michael A. Gorin; Obi Ekwenna; Mark S. Soloway; Gaetano Ciancio

doi:10.1016/j.urology.2011.04.018

Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery

Michael A. Gorin, Obi Ekwenna, Mark S. Soloway, Gaetano Ciancio

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Neoadjuvant sunitinib has recently been described for the management of renal cell carcinoma. We present the pre and posttreatment images of a 49-year-old male with bilateral biopsy-proven clear cell renal cell carcinoma who underwent treatment with sunitinib prior to nephron-sparing surgery. After four four-week cycles of daily 50 mg sunitinib, the patient demonstrated a dramatic reduction in tumor burden allowing for successful bilateral partial nephrectomy.

Original language	English (US)
Pages (from-to)	e11
Journal	Urology
Volume	79
Issue number	2
DOIs	https://doi.org/10.1016/j.urology.2011.04.018
State	Published - Feb 2012
Externally published	Yes

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.urology.2011.04.018

Cite this

@article{4b5d16b5543c480c9f1ccacd110d0fb3,

title = "Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery",

abstract = "Neoadjuvant sunitinib has recently been described for the management of renal cell carcinoma. We present the pre and posttreatment images of a 49-year-old male with bilateral biopsy-proven clear cell renal cell carcinoma who underwent treatment with sunitinib prior to nephron-sparing surgery. After four four-week cycles of daily 50 mg sunitinib, the patient demonstrated a dramatic reduction in tumor burden allowing for successful bilateral partial nephrectomy.",

author = "Gorin, {Michael A.} and Obi Ekwenna and Soloway, {Mark S.} and Gaetano Ciancio",

year = "2012",

month = feb,

doi = "10.1016/j.urology.2011.04.018",

language = "English (US)",

volume = "79",

pages = "e11",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery

AU - Gorin, Michael A.

AU - Ekwenna, Obi

AU - Soloway, Mark S.

AU - Ciancio, Gaetano

PY - 2012/2

Y1 - 2012/2

N2 - Neoadjuvant sunitinib has recently been described for the management of renal cell carcinoma. We present the pre and posttreatment images of a 49-year-old male with bilateral biopsy-proven clear cell renal cell carcinoma who underwent treatment with sunitinib prior to nephron-sparing surgery. After four four-week cycles of daily 50 mg sunitinib, the patient demonstrated a dramatic reduction in tumor burden allowing for successful bilateral partial nephrectomy.

AB - Neoadjuvant sunitinib has recently been described for the management of renal cell carcinoma. We present the pre and posttreatment images of a 49-year-old male with bilateral biopsy-proven clear cell renal cell carcinoma who underwent treatment with sunitinib prior to nephron-sparing surgery. After four four-week cycles of daily 50 mg sunitinib, the patient demonstrated a dramatic reduction in tumor burden allowing for successful bilateral partial nephrectomy.

UR - http://www.scopus.com/inward/record.url?scp=84856698843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856698843&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2011.04.018

DO - 10.1016/j.urology.2011.04.018

M3 - Article

C2 - 21676439

AN - SCOPUS:84856698843

SN - 0090-4295

VL - 79

SP - e11

JO - Urology

JF - Urology

IS - 2

ER -

Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this